Hexima Limited announces that Dr. Nicole van der Weerden, its Acting CEO and former COO, will step down from her executive responsibilities effective 31 December, 2022. Dr. van der Weerden will continue as a Non-Executive Director of the Company and continue to support Hexima through this transition period. This step is consistent with Hexima's previously announced intention to manage expenses associated with non-essential employees in a cost effective and orderly manner.

Hexima's operational activities have been largely wound down over the past 6 months, reducing the need for a full-time CEO. The Board continues to advance its stated strategic goal of maximizing shareholder value through a transaction, supported by the Company's contract Company Secretary and contract CFO.